[Association between HLA and disease. Current status and perspectives].
D001327:Autoimmune Diseases / Q000235:genetics / Q000276:immunology; D003165:Complement System Proteins / Q000172:deficiency; D003874:Dermatitis Herpetiformis / Q000276:immunology; D003877:Dermatitis, Contact / Q000276:immunology; D006680:HLA Antigens / Q000032:analysis* / Q000145:classification / Q000235:genetics; D006684:HLA-DR Antigens; D006561:Herpes Simplex / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000276:immunology; D007239:Infections / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D010391:Pemphigoid, Bullous / Q000276:immunology; D010392:Pemphigus / Q000276:immunology; D011164:Porphyrias / Q000276:immunology; D011565:Psoriasis / Q000276:immunology; D012871:Skin Diseases / Q000276:immunology*; D009626:Terminology as Topic; D001613:beta 2-Microglobulin / Q000276:immunology
D006680:HLA Antigens; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D001613:beta 2-Microglobulin; D003165:Complement System Proteins
Asociación entre HLA y enfermedad. Estado actual y perspectivas.